Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM) [Phase 2]
Phase 2 clinical trial evaluating Lenalidomide, Bortezomib, and Dexamethasone for multiple myeloma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma [NA]
Results from a completed clinical trial examining immune reconstitution after autologous hematopoietic stem cell transplantation in high-ris…
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma [Phase 3]
Phase 3 trial comparing denosumab with zoledronic acid for bone disease in multiple myeloma completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-03-05Clinical Trial Update: Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments [Phase 1, Phase 2]
Clinical trial evaluating carfilzomib in multiple myeloma patients relapsed or refractory to bortezomib has completed Phase 1/Phase 2.
-
CLINICAL_TRIALS trial_result · 2018-03-05Clinical Trial Update: Safety, Efficacy, and Pharmacodynamics of a 60-Minute Infusion of Carfilzomib for Progressive Multiple Myeloma [Phase 1, Phase 2]
A clinical trial update evaluating the safety, early efficacy, and pharmacodynamics of a 60-minute infusion of carfilzomib for progressive m…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-03-05Clinical Trial Update: Serum Vitamin D Levels and Peripheral Neuropathy Among Multiple Myeloma Patients
Update on the relationship between serum vitamin D levels and peripheral neuropathy in patients with multiple myeloma. The study status is c…
-
CLINICAL_TRIALS trial_result · 2018-03-01Clinical Trial Update: A Study of Mircera in Anemic Patients With Multiple Myeloma [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated Mircera for treating anemia in patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2018-02-28Clinical Trial Update: Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma [Phase 2]
Phase 2 trial evaluating perifosine alone and in combination with dexamethasone in patients with multiple myeloma reports efficacy updates.
-
CLINICAL_TRIALS research · 2018-02-28Clinical Trial Update: Comprehensive Frailty Assessment
This update notes the completion of a study evaluating Comprehensive Frailty Assessment in patients with multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients [Phase 1, Phase 2]
Phase 1/2 trial assessing perifosine with bortezomib with or without dexamethasone in multiple myeloma; completed study.
-
CLINICAL_TRIALS trial_result · 2018-02-09Clinical Trial Update: Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients [Phase 3]
Phase 3 trial assessing perifosine with bortezomib and dexamethasone in multiple myeloma was terminated.
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating SMAC mimetic LCL161 alone or with cyclophosphamide in relapsed or refractory multiple myeloma; study compl…
-
CLINICAL_TRIALS trial_result · 2018-01-31Clinical Trial Update: Study of Pomalidomide, Dexamethasone, and Romidepsin for Rel/Ref Myeloma [Phase 1, Phase 2]
A phase 1/2 trial evaluating pomalidomide, dexamethasone, and romidepsin for relapsed/refractory multiple myeloma was terminated. Results we…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Study of Oral Ixazomib in Combination With Melphalan and Prednisone in Participants With Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating oral ixazomib in combination with melphalan and prednisone for newly diagnosed multiple myeloma has completed w…
-
CLINICAL_TRIALS trial_result · 2018-01-19Clinical Trial Update: Comparison of 25mg Versus 5 mg Lenalidomide as Maintenance Therapy in Patients With Multiple Myeloma [Phase 3]
A Phase 3 clinical trial compared 25 mg versus 5 mg lenalidomide as maintenance therapy in multiple myeloma and has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation [Phase 3]
Phase 3 trial comparing VCD to CTD in newly diagnosed multiple myeloma patients eligible for transplantation completed.
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma [Phase 2]
Phase 2 trial update on non-myeloablative allogeneic transplantation for multiple myeloma; study completed with results posted in 2018.
-
FDA approval · 2018-01-17FDA Approved: KYPROLIS — Supplemental Application (Onyx Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Kyprolis (carfilzomib) submitted by Onyx Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: A Phase 1b/2, Dose-Escalation Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Relapsed Multiple Myeloma [Phase 2]
Phase 1b/2 dose-escalation study of elotuzumab in relapsed multiple myeloma has completed phase 2 with results posted.
-
FDA approval · 2017-12-29FDA Approved: POMALYST — Supplemental Application (Celgene Corporation)
The FDA approved a supplemental application for POMALYST (pomalidomide) submitted by Celgene Corporation. The action updates the regulatory …
-
CLINICAL_TRIALS trial_result · 2017-12-29Clinical Trial Update: Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure Patients [Phase 2]
Phase 2 clinical trial evaluating lenalidomide combined with high-dose dexamethasone in untreated multiple myeloma patients with renal failu…
-
CLINICAL_TRIALS trial_result · 2017-12-29Clinical Trial Update: Study of BCMA CAR-T in Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for a BCMA CAR-T therapy in multiple myeloma; current status is unknown.
-
FDA approval · 2017-12-22FDA Approved: MELPHALAN — Original Application (Fresenius Kabi USA, LLC)
The FDA approved Fresenius Kabi USA, LLC's original application for melphalan hydrochloride (melphalan hydrochloride) as a generic chemother…
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients [Phase 2]
Phase 2 clinical trial update evaluating PD and safety of TG-0054 in combination with G-CSF for patients with multiple myeloma and lymphomas…
-
CLINICAL_TRIALS withdrawal · 2017-12-13Clinical Trial Update: Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma [Phase 1, Phase 2]
The Phase 1/2 trial evaluating melphalan with total marrow irradiation and autologous stem cell transplantation for high-risk multiple myelo…